CFX™, injected as a cell-free product, can prevent future heart failure following acute myocardial infarction (CFX™ Solus) and in combination with therapeutic stem cells (CFX™ Tandem), where it enhances cell retention and thus the effective dose to revitalize scarred myocardium and rescue patients from chronic heart failure.